Abstract RF01-03: PARSIFAL-LONG: Extended Follow-Up of Hormone Receptor-Positive/her2-negative Advanced Breast Cancer Patients Treated with Fulvestrant and Palbociclib Vs. Letrozole and Palbociclib in the PARSIFAL Study
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined